Journal of Ovarian Research
Scope & Guideline
Shaping the future of gynecological and oncological studies.
Introduction
Aims and Scopes
- Ovarian Cancer Research:
The journal consistently publishes studies on various aspects of ovarian cancer, including molecular mechanisms, therapeutic strategies, and biomarkers for diagnosis and prognosis. - Polycystic Ovary Syndrome (PCOS):
A significant number of articles focus on the pathophysiology, diagnosis, and treatment of PCOS, exploring its impact on fertility and metabolic health. - Reproductive Technologies:
Research on assisted reproductive technologies (ART), such as IVF/ICSI, and their outcomes, particularly in relation to ovarian function and response, is a recurring theme. - Stem Cell Applications:
The journal highlights innovative research involving stem cells and their potential therapeutic applications in ovarian health and reproductive disorders. - Molecular and Genetic Studies:
There is a strong emphasis on genomic and molecular studies that investigate the genetic underpinnings of ovarian diseases and reproductive health. - Endocrinology and Metabolism:
Research related to hormonal regulation in ovarian function, including the effects of metabolic disorders on ovarian health, is prominently featured. - Environmental and Lifestyle Factors:
The impact of environmental toxins, diet, and lifestyle on ovarian function and health is increasingly becoming a focal point of research.
Trending and Emerging
- Extracellular Vesicles and Their Role in Ovarian Health:
Research on extracellular vesicles, particularly their roles in communication between ovarian cells and their implications in cancer and reproductive health, is gaining momentum. - Ferroptosis in Ovarian Disorders:
The emerging role of ferroptosis, a form of regulated cell death, in ovarian health and diseases, particularly in the context of ovarian cancer and infertility, is increasingly highlighted. - Machine Learning and AI in Ovarian Research:
The integration of machine learning and artificial intelligence for predictive modeling and diagnostics in ovarian cancer and reproductive health is a growing theme. - Personalized Medicine Approaches:
There is an increasing focus on personalized medicine strategies in the management of ovarian cancer and reproductive disorders, tailoring treatments based on individual patient profiles. - Gut Microbiome and Ovarian Health:
Research exploring the relationship between the gut microbiome and ovarian function, particularly in conditions like PCOS, is emerging as a significant area of interest. - Immunotherapy in Ovarian Cancer:
The exploration of immunotherapeutic approaches for ovarian cancer treatment is gaining traction, reflecting broader trends in oncology. - Genetic and Epigenetic Factors in Ovarian Disorders:
There is a rising emphasis on the role of genetic and epigenetic factors in the development and treatment of ovarian diseases, particularly in cancer and PCOS.
Declining or Waning
- Traditional Fertility Treatments:
There has been a noticeable decline in research focused solely on traditional fertility treatments without the incorporation of newer technologies or methodologies. - Basic Ovarian Physiology:
Studies focusing exclusively on basic ovarian physiology, without direct application to clinical or translational research, seem to be less frequent. - Ovarian Aging without Therapeutic Context:
Research on ovarian aging that does not explore potential therapeutic interventions or implications for fertility is becoming less common. - Single-Cohort Studies:
The prevalence of single-cohort studies without broader comparative analyses or multi-center collaborations appears to be decreasing. - Epidemiological Studies without Molecular Insights:
Epidemiological research focused on ovarian disorders without accompanying molecular or genetic insights is becoming less frequent.
Similar Journals
Hormones-International Journal of Endocrinology and Metabolism
Advancing the Frontiers of Hormonal ScienceHormones - International Journal of Endocrinology and Metabolism, published by Springer International Publishing AG, is a vital resource within the field of Endocrinology, Diabetes, and Metabolism. Since its inception in 2005, this journal has made significant contributions to the understanding of hormonal mechanisms and their implications across various medical disciplines. With a current impact factor that places it in the Q3 category for Endocrinology and the Q2 category for miscellaneous Medicine – as indicated by its Scopus rankings – it stands out as a reputable platform for cutting-edge research and clinical findings. Although it operates under a subscription model, the journal's comprehensive scope encompasses basic and applied scientific studies, making it essential reading for researchers, clinicians, and students alike. The journal is headquartered in Germany with a strong commitment to promoting scholarly communication and knowledge dissemination within its specialized fields through the year 2024 and beyond.
GEBURTSHILFE UND FRAUENHEILKUNDE
Shaping the Future of Women's Health Together.GEBURTSHILFE UND FRAUENHEILKUNDE is a prestigious journal dedicated to the fields of Maternity, Midwifery, Obstetrics, and Gynecology, published by GEORG THIEME VERLAG KG, a reputable publisher known for its commitment to advancing medical knowledge. Established in 1947, the journal has consistently provided a platform for high-quality research and clinical studies that address current challenges and innovations in women's health. With an impact factor positioned in Q2 for Maternity and Midwifery and Q3 in Obstetrics and Gynecology, it ranks among the top journals within its field, further solidified by its Scopus rankings highlighting its influential presence. Although the journal is not open access, it remains an essential resource for academics and practitioners keen to stay informed on the latest evidence-based practices and cutting-edge research, ensuring that all stakeholders in women's healthcare can access critical insights to enhance patient outcomes.
GYNECOLOGICAL ENDOCRINOLOGY
Championing Open Access to Women's Health ResearchGYNECOLOGICAL ENDOCRINOLOGY is a prestigious open-access journal published by Taylor & Francis Ltd, focusing on the dynamic fields of endocrinology, obstetrics, and gynecology. With its ISSN of 0951-3590 and E-ISSN of 1473-0766, this journal provides a vital platform for the dissemination of high-quality research and advancements in gynecological endocrinology since its inception in 1987. Notably, it attained an Open Access status in 2023, enhancing its reach and accessibility to researchers and practitioners worldwide. The journal is renowned for its rigorous peer-review process and holds significant standing with a Q2 ranking in Obstetrics and Gynecology and a Q3 ranking in Endocrinology, Diabetes, and Metabolism, as of 2023. It is indexed with commendable Scopus ranks in various medical domains, offering a reliable resource for current methodologies and future directions in gynecological health. With the growing emphasis on women's health and endocrinological research, GYNECOLOGICAL ENDOCRINOLOGY serves as an essential repository for innovative studies, clinical insights, and emerging therapeutic strategies, making it an invaluable resource for researchers, clinicians, and students alike.
Familial Cancer
Connecting research and clinical practice in genetics.Familial Cancer is a premier journal dedicated to advancing the understanding of hereditary cancer, published by Springer. With an ISSN of 1389-9600 and E-ISSN 1573-7292, this journal serves as an essential platform for researchers and clinicians focused on the genetic predispositions to cancer and the implications for patient care. Since its inception in 2001, Familial Cancer has built a strong reputation, being consistently ranked in the Q2 category across several key research areas including Cancer Research, Genetics, and Oncology. As of 2023, it holds significant Scopus rankings, reflecting its impactful contributions in the fields of Medicine and Genetics, with a focus on clinical applications. The journal does not currently offer Open Access, emphasizing the commitment to rigorous peer review and high-quality publications. It is vital for emerging researchers and seasoned professionals alike, providing insights into the hereditary aspects of cancer and fostering developments that can lead to better prevention and therapeutic strategies.
Reproductive Medicine
Connecting Ideas, Cultivating Solutions in Reproductive HealthReproductive Medicine is an esteemed open-access journal published by MDPI, focusing on the latest research and advances in reproductive health, fertility, and assisted reproductive technologies. With its E-ISSN of 2673-3897, the journal aims to provide a platform for researchers, clinicians, and healthcare professionals to disseminate their findings, share innovative practices, and engage in scholarly discourse. Situated in Basel, Switzerland, Reproductive Medicine emphasizes a multidisciplinary approach, exploring biological, clinical, and psychological aspects of reproductive health. Although the journal is in the early stages of establishing metrics such as H-index and Scopus rankings, its open-access model enhances accessibility, allowing for a broad dissemination of knowledge. Committed to fostering advancements in the field, Reproductive Medicine is essential for those seeking to stay at the forefront of reproductive health research.
ENDOCRINE JOURNAL
Shedding light on the pathophysiology of endocrine disorders.ENDOCRINE JOURNAL, published by the Japan Endocrine Society, is a pivotal resource for researchers and professionals in the field of endocrinology, diabetes, and metabolism. With a long history dating back to 1954, this journal encompasses a comprehensive range of topics including hormonal regulation, pathophysiology of endocrine diseases, and innovative therapeutic approaches. Despite its classification as open access, the journal remains a beacon of knowledge, with impressive rankings—Q2 in Endocrinology, Diabetes and Metabolism and Q3 in Endocrinology for 2023—ensuring it is a respected source in the academic community. It serves as a critical platform for the dissemination of cutting-edge research, encouraging collaboration and facilitating advancements in understanding complex endocrine disorders. By subscribing to this journal, researchers and students gain access to seminal studies, clinical insights, and a wealth of information that drives this vital field forward.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
Advancing knowledge in women's reproductive health.INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, published by Lippincott Williams & Wilkins, is a premier academic journal dedicated to the intricate field of gynecological pathology, serving a critical role in advancing the understanding of diseases related to women's reproductive health. Since its inception in 1982, this journal has established itself as a key resource for researchers, clinicians, and students, with a current impact factor that reflects its esteemed reputation; it is ranked in the Q2 category for both Obstetrics and Gynecology, as well as Pathology and Forensic Medicine, signifying its prominence in academic circles. The journal's scope encompasses a wide array of topics, including histopathological findings, diagnostic methodologies, and evolving therapeutic strategies, all pivotal to enhancing patient care. With a steadfast commitment to disseminating high-quality research until the projected year of 2024, the INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY is an essential read for those looking to stay abreast of the latest developments in this vital area of medical science.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
Fostering Global Insights in Women's HealthThe INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, published by Wiley, stands as a prestigious and influential resource in the fields of medicine and obstetrics and gynecology. With its ISSN 0020-7292 and E-ISSN 1879-3479, this journal has been at the forefront of scholarly communication since its inception in 1973, extending its reach and impact through to 2024. Ranked in the Q1 quartile in both medicine miscellaneous and obstetrics and gynecology, and positioned impressively at 39th out of 209 in the Scopus rankings, the journal is renowned for its rigorous peer-reviewed articles that advance the understanding and practice of gynecological and obstetric health. The importance of this journal is underscored by its role in disseminating cutting-edge research and fostering innovation in clinical practices, making it an essential reading for researchers, healthcare professionals, and students alike. While it does not offer open access, its robust subscription model ensures a wealth of valuable information is accessible to those dedicated to improving women's health globally.
International Journal of Fertility & Sterility
Championing Excellence in Reproductive ResearchThe International Journal of Fertility & Sterility, published by ROYAN Institute, is a leading academic platform dedicated to advancing knowledge in the fields of obstetrics, gynecology, and reproductive medicine. With an ISSN of 2008-076X and an E-ISSN of 2008-0778, this Open Access journal has been making significant contributions to the scientific community since its inception in 2007. Based in Tehran, Iran, the journal showcases rigorous research and promotes interdisciplinary collaboration, addressing critical topics related to fertility, sterility, and reproductive health. As of 2023, it holds an impressive Q2 ranking in Obstetrics and Gynecology and a Q3 ranking in Reproductive Medicine, underscoring its relevance and impact in the academic sphere, with Scopus ranks placing it at #67 in Obstetrics and Gynecology and #32 in Reproductive Medicine. The journal's commitment to accessibility and quality is reflected in its global readership, making it an essential resource for researchers, healthcare professionals, and students seeking to enhance their understanding of fertility issues and reproductive technologies.
ENDOCRINE RESEARCH
Pioneering discoveries in endocrine health.ENDOCRINE RESEARCH is a prominent peer-reviewed journal published by TAYLOR & FRANCIS INC, focused on the dynamic field of endocrinology. With an ISSN of 0743-5800 and an E-ISSN of 1532-4206, this journal has been contributing to the scientific community since 1974, providing a platform for researchers to disseminate innovative findings related to hormonal research and its implications in diverse medical contexts. Operating from the United States, it falls within the Q3 quartile ranking in both Endocrinology and Medicine (Miscellaneous), reflecting its recognized impact within these disciplines. While ENDOCRINE RESEARCH currently does not offer open access options, it remains an invaluable resource for professionals, students, and researchers seeking to stay at the forefront of endocrine science and clinical application. The journal invites original research articles, reviews, and case studies, fostering a collaborative environment for discussing the complexities of endocrinological phenomena.